APA (7th ed.) Citation

N, F., AC, F., L, P., B, M., F, P., P, D. G., . . . L, C. (2022). Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer's disease. Frontiers in aging neuroscience, 14, 1004002. https://doi.org/10.3389/fnagi.2022.1004002

Chicago Style (17th ed.) Citation

N, Forte, Fernández-Rilo AC, Palomba L, Marfella B, Piscitelli F, De Girolamo P, Di Costanzo A, Di Marzo V, and Cristino L. "Positive Association Between Plasmatic Levels of Orexin A and the Endocannabinoid-derived 2-arachidonoyl Lysophosphatidic Acid in Alzheimer's Disease." Frontiers in Aging Neuroscience 14 (2022): 1004002. https://doi.org/10.3389/fnagi.2022.1004002.

MLA (9th ed.) Citation

N, Forte, et al. "Positive Association Between Plasmatic Levels of Orexin A and the Endocannabinoid-derived 2-arachidonoyl Lysophosphatidic Acid in Alzheimer's Disease." Frontiers in Aging Neuroscience, vol. 14, 2022, p. 1004002, https://doi.org/10.3389/fnagi.2022.1004002.